Lepu Biopharma gets taste of spring with first revenues
抗癌藥首錄收入 樂普生物迎收成
The ADC-focused drug company logged its first-ever sales late last year, kicking of the next phase of its development
這家主攻抗體偶聯藥物的藥商首次錄得銷售收入，準備踏入收成期。
This article only represents the author's own views.
您已閱讀1%（69字），剩餘99%（8420字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。